180 related articles for article (PubMed ID: 19879919)
1. Role of NF-kappaB in thyroid cancer.
Pacifico F; Leonardi A
Mol Cell Endocrinol; 2010 May; 321(1):29-35. PubMed ID: 19879919
[TBL] [Abstract][Full Text] [Related]
2. Thyroid cancer and inflammation.
Guarino V; Castellone MD; Avilla E; Melillo RM
Mol Cell Endocrinol; 2010 May; 321(1):94-102. PubMed ID: 19835928
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology of differentiated thyroid cancer.
Greco A; Borrello MG; Miranda C; Degl'Innocenti D; Pierotti MA
Q J Nucl Med Mol Imaging; 2009 Oct; 53(5):440-53. PubMed ID: 19910897
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor alpha induces three-dimensional cytomorphologic differentiation of human anaplastic thyroid carcinoma cells through activation of nuclear factor kappaB.
Wang CY; Zhong WB; Chang TC; Lai SM; Tsai YF
Cancer; 2002 Nov; 95(9):1827-33. PubMed ID: 12404274
[TBL] [Abstract][Full Text] [Related]
5. Bridging hypoxia, inflammation and estrogen receptors in thyroid cancer progression.
Tafani M; De Santis E; Coppola L; Perrone GA; Carnevale I; Russo A; Pucci B; Carpi A; Bizzarri M; Russo MA
Biomed Pharmacother; 2014 Feb; 68(1):1-5. PubMed ID: 24286852
[TBL] [Abstract][Full Text] [Related]
6. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Starenki DV; Namba H; Saenko VA; Ohtsuru A; Maeda S; Umezawa K; Yamashita S
Clin Cancer Res; 2004 Oct; 10(20):6821-9. PubMed ID: 15501958
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta-induced apoptosis in human thyrocytes is mediated by p27kip1 reduction and is overridden in neoplastic thyrocytes by NF-kappaB activation.
Bravo SB; Pampín S; Cameselle-Teijeiro J; Carneiro C; Domínguez F; Barreiro F; Alvarez CV
Oncogene; 2003 Oct; 22(49):7819-30. PubMed ID: 14586408
[TBL] [Abstract][Full Text] [Related]
8. New molecular targeted therapies in thyroid cancer.
Milano A; Chiofalo MG; Basile M; Salzano de Luna A; Pezzullo L; Caponigro F
Anticancer Drugs; 2006 Sep; 17(8):869-79. PubMed ID: 16940797
[TBL] [Abstract][Full Text] [Related]
9. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of synthetic serine protease inhibitor (FUT-175)-mediated cell death.
Uwagawa T; Li Z; Chang Z; Xia Q; Peng B; Sclabas GM; Ishiyama S; Hung MC; Evans DB; Abbruzzese JL; Chiao PJ
Cancer; 2007 May; 109(10):2142-53. PubMed ID: 17410536
[TBL] [Abstract][Full Text] [Related]
11. Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells.
Chiao PJ; Na R; Niu J; Sclabas GM; Dong Q; Curley SA
Cancer; 2002 Oct; 95(8):1696-705. PubMed ID: 12365017
[TBL] [Abstract][Full Text] [Related]
12. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
[TBL] [Abstract][Full Text] [Related]
13. NF-kappaB, inflammation and pancreatic carcinogenesis: NF-kappaB as a chemoprevention target (review).
Zhang Z; Rigas B
Int J Oncol; 2006 Jul; 29(1):185-92. PubMed ID: 16773199
[TBL] [Abstract][Full Text] [Related]
14. NF-kappaB and IKK as therapeutic targets in cancer.
Kim HJ; Hawke N; Baldwin AS
Cell Death Differ; 2006 May; 13(5):738-47. PubMed ID: 16485028
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB in solid tumors.
Pacifico F; Leonardi A
Biochem Pharmacol; 2006 Oct; 72(9):1142-52. PubMed ID: 16956585
[TBL] [Abstract][Full Text] [Related]
16. IkappaB kinase beta (IKKbeta/IKK2/IKBKB)--a key molecule in signaling to the transcription factor NF-kappaB.
Schmid JA; Birbach A
Cytokine Growth Factor Rev; 2008 Apr; 19(2):157-65. PubMed ID: 18308615
[TBL] [Abstract][Full Text] [Related]
17. Targeting the NF-kappa B pathway in estrogen receptor negative MDA-MB-231 breast cancer cells using small inhibitory RNAs.
Monks NR; Pardee AB
J Cell Biochem; 2006 May; 98(1):221-33. PubMed ID: 16408291
[TBL] [Abstract][Full Text] [Related]
18. The NF-kappaB transcription factor pathway as a therapeutic target in cancer: methods for detection of NF-kappaB activity.
Mauro C; Zazzeroni F; Papa S; Bubici C; Franzoso G
Methods Mol Biol; 2009; 512():169-207. PubMed ID: 19347278
[TBL] [Abstract][Full Text] [Related]
19. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells.
Mitsutake N; Knauf JA; Mitsutake S; Mesa C; Zhang L; Fagin JA
Cancer Res; 2005 Mar; 65(6):2465-73. PubMed ID: 15781663
[TBL] [Abstract][Full Text] [Related]
20. NF-kappaB modulation and ionizing radiation: mechanisms and future directions for cancer treatment.
Magné N; Toillon RA; Bottero V; Didelot C; Houtte PV; Gérard JP; Peyron JF
Cancer Lett; 2006 Jan; 231(2):158-68. PubMed ID: 16399220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
